https://www.youtube.com/watch?v=cdkl4IyPweQ

Welcome to FOXO BioScience,
the Longevity Company

Modernizing the longevity insurance industry with molecular biotechnology.

What We Do

We’re pioneering the discovery, development, and integration of epigenetic biomarkers for the longevity insurance industry.

Supervised maching learning is applied to epigenetic signatures and DNA methylation analysis.

Epigenetic Testing

LEARN MORE
Bioinformatics and artifical intelligence technologies are applied to Epigenetic Signatures and DNA Methylation Analysis.

Insurance Underwriting

LEARN MORE

Molecular Age Technology

LEARN MORE

Why We Do It

We believe that changes to the human epigenome are a fundamental mechanism of aging and disease.

As we reimagine the future of longevity insurance underwriting and support the growth of global longevity markets with a next-generation underwriting protocol, we seek to discover and understand the role epigenetic biomarkers play in individual health, wellness, and aging in order to empower people to improve the length and quality of their lives, and make more informed choices that benefit their health.

While a person’s underlying genetic code is stable throughout life, their health, wellness and aging leave discernible marks on the genome that modify how genes are expressed. The epigenome is the combination of all such natural modifications; while epigenetic modifications can register within seconds to minutes, they can imprint signatures on the epigenome for decades, leaving a unique biography of an individual’s health and wellness history.

How changes to the human epigenome can cause genes to express in a way that causes chronic illness and disease.
Smoking tobacco is a leading cause of cancer
Stress promotes Cardiovascular Disease
Obesity can cause genes to express as Diabetes
Diet & Exercise can increase/decrease Disease States

How We Do It

To identify epigenetic biomarkers along the epigenome, we apply advanced supervised machine learning and artificial intelligence technologies to create predictive models that correlate epigenetic profiles with states of health, wellness, disease, and aging. Our high throughput, CLIA-certified laboratories also support human and mouse epigenetic methylation testing for the scientific research community.

Who We Serve

Research Community

As a molecular biotechnology company, we are developing innovative new products and epigenetic testing services that provide cost-effective solutions for the scientific research community.

LEARN MORE

Longevity Industry

We are using epigenetics to reimagine the future of life insurance with a next-generation underwriting protocol and consumer engagement platform focused on improving human health and lifespan.

LEARN MORE

Our Ecosystem

We collaborate with some of the nation’s leading bioscience and biotechnology companies, academic institutions, and science education organizations to develop cutting-edge epigenetic technology.

Follow our CEO, Jon Sabes’ approach to longevity and legacy.

GO TO BLOG

Featured Articles

FOXO in Coverager & SCOR

Learn how we are modernizing the longevity insurance industry with a new underwriting protocol and a reimagined customer engagement platform to improve healthspan and lifespan.

READ ARTICLE

FOXO in On the Risk

Read about the current state of insurance underwriting and how we are using molecular biotechnology to reimagine it in “The Need to Evolve Preferred Underwriting” by FOXO Chief Underwriter, Bill Moore.

READ ARTICLE

FOXO in Society of Actuaries

Understand how the science of epigenetics is positioned to impact life insurance, and learn how the utilization of epigenetic biomarkers for underwriting could transform the longevity insurance industry.

READ ARTICLE

Epigenetics & Longevity in the Media

David Sinclair & Joe Rogan

Our journey started with Dr. Steve Horvath’s research into aging. Listen to Dr. David Sinclair explain who Dr. Horvath is and why our technology is fundamental to understanding aging.

Understanding the Biomarkers of Aging

Professor of Human Genetics and Biostatistics at UCLA, Dr. Steve Horvath discusses epigenetic clocksthe biomarkers of agingand the consequences of epigenetic aging.

The Power of the
Epigenetic Clock

In this TEDxBerkeley Talk, Dr. Steve Horvath of the University of California, Los Angeles explores how epigenetic clocks are currently being used to discover anti-aging treatments.

Follow along on our journey to transform the global longevity insurance industry.

When you subscribe, you’ll receive occasional emails from FOXO BioScience.

You may unsubscribe whenever you wish.